Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS

被引:106
作者
Ding, QX [1 ]
Dimayuga, E [1 ]
Keller, JN [1 ]
机构
[1] Univ Kentucky, Dept Anat & Neurobiol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
关键词
D O I
10.1089/ars.2006.8.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteasome-mediated protein degradation is responsible for a large percentage of bulk protein turnover, particularly the degradation of short-lived and oxidized proteins. Increasing evidence suggests that proteasome inhibition occurs during the aging of the central nervous system (CNS), and in a variety of age-related disorders of the CNS. The focus of this review is to discuss the role of the proteasome as a regulator of oxidative stress, with preservation of proteasome function playing an important role in preventing oxidative stress, and proteasome inhibition playing an important role as a mediator of oxidative stress. In particular, this review will describe experimental evidence that proteasome inhibition is sufficient to induce mitochondrial dysfunction, increase reactive oxygen species generation, elevate RNA and DNA oxidation, and promote protein oxidation. Taken together, these data indicate that the proteasome is an important regulator of oxidative damage in the CNS, and suggest that proteasome inhibition may serve as an important switch for the induction of oxidative stress in the CNS. Additionally we discuss the likelihood that the 20S proteasome and 26S proteasome may play different roles in regulating oxidative stress and neurotoxicity in the aging CNS, and in age-related disorders of the CNS.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 101 条
[61]   The proteasome in brain aging [J].
Keller, JN ;
Gee, J ;
Ding, QX .
AGEING RESEARCH REVIEWS, 2002, 1 (02) :279-293
[62]   20S proteasome biogenesis [J].
Krüger, E ;
Kloetzel, PM ;
Enenkel, C .
BIOCHIMIE, 2001, 83 (3-4) :289-293
[63]   Investigating the importance of proteasome-interaction for Rad23 function [J].
Lambertson, D ;
Chen, L ;
Madura, K .
CURRENT GENETICS, 2003, 42 (04) :199-208
[64]   Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway [J].
Lang-Rollin, I ;
Vekrellis, K ;
Wang, Q ;
Rideout, HJ ;
Stefanis, L .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (06) :1511-1520
[65]   Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway [J].
Lee, HJ ;
Khoshaghideh, F ;
Patel, S ;
Lee, SJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (08) :1888-1896
[66]   Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells [J].
Ling, YH ;
Liebes, L ;
Zou, YY ;
Perez-Soler, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :33714-33723
[67]   Oxidative stress hypothesis in Alzheimer's disease [J].
Markesbery, WR .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (01) :134-147
[68]  
Markesbery WR, 1999, BRAIN PATHOL, V9, P133
[69]   Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease [J].
McNaught, KSP ;
Perl, DP ;
Brownell, AL ;
Olanow, CW .
ANNALS OF NEUROLOGY, 2004, 56 (01) :149-162
[70]   Proteolysis, caloric restriction and aging [J].
Merker, K ;
Stolzing, A ;
Grune, T .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (07) :595-615